Courter v. CytoDyn Inc

• Court: District Court, W.D. Washington
• Decided: July 22, 2021
• Docket: 3:21-cv-05190
• Status: Unknown

Opinion

1 2

5 UNITED STATES DISTRICT COURT 6 WESTERN DISTRICT OF WASHINGTON AT TACOMA 7 ANGELA LEWIS, individually and on CASE NO. C21-5190 BHS 8 behalf of all others similarly situated ORDER REQUESTING 9 Plaintiff, SURREPLY v. 10 CYTODYN, INC., 11 Defendant. 12

13 This matter comes before the Court on Movant Dr. Smila Kodali’s motion to 14 consolidate actions, appoint lead plaintiff, and approve her selection of lead and liaison 15 counsel, Dkt. 22, and Movant Brian Joe Courter and Courter and Sons LLC’s 16 (collectively “Courter”) motion for consolidation of related actions, appointment as lead 17 plaintiff, and approval of selection of counsel, Dkt. 26. 18 This action is a putative securities class action lawsuit against Defendant 19 CytoDyn, Inc. and two of its executive officers, Defendants Nader Pourhassen and 20 Michael Mulholland. Dkt. 1. The action asserts claims on behalf of a proposed class of all 21 persons or entities who purchased or otherwise acquired CytoDyn common stock 22 1 between March 27, 2020 and March 9, 2021 (the “Class Period”). Id. ¶ 1. On March 18, 2 2021, Plaintiff Angela Lewis (the first-filed Plaintiff) published notice pursuant to the

3 Private Securities Litigation Reform Act of 1995 (“PSLRA”), 15 U.S.C. § 78u-4(a)(1)– 4 (3)(B)(i), over Globe Newswire, a widely circulated national business-oriented wire 5 service. See Dkt. 24-4. Members of the purported class have 60 days after the date on 6 which the notice is published to move the court to serve as lead plaintiff. 15 U.S.C. 7 § 78u-4(a)(3)(A)(i)(II). 8 On May 17, 2021, motions to consolidate cases and to appoint lead plaintiff and

9 approve selection of counsel were filed by Plaintiff Lewis, Dkt. 12, Movant Charles 10 Huang, Dkt. 14, Movants Candra Evans and Kenneth Kirschenbaum, Dkt. 17, Movant 11 Michael O’Donnell, Dkt. 19, Movant Ho “Matt” Chun, Dkt. 21, Movant Dr. Smila 12 Kodali, Dkt. 22, and Movants Brian Joe Courter and Courter and Sons, LLC, Dkt. 26. 13 Notices of non-opposition to competing lead plaintiff motions were then filed by

14 O’Donnell, Dkt. 41, Huang, Dkt. 43, Evans and Kirschenbaum, Dkt. 44, and Chun 15 withdrew his motion to appoint, Dkt. 42. Lewis did not file a response or a notice of non- 16 opposition.1 17 Thus, the remaining two movants for lead plaintiff are Kodali and Courter. On 18 June 1, 2021, both Kodali and Courter responded to the other Movants’ motions. Dkts.

20 1 “Except for motions for summary judgment, if a party fails to file papers in opposition to a motion, such failure may be considered by the court as an admission that the motion has 21 merit.” Local Rules, W.D. Wash. LCR 7(b)(2). The Court construes Lewis’s failure to respond as an admission that she does not oppose the Court’s appointment of Kodali or Courter as lead 22 plaintiff. 1 45, 47. On June 4, 2021, Kodali and Courter replied to the others’ responses. Dkts. 50, 2 51. On June 9, 2021, Kodali filed a surreply, requesting that the Court strike footnote 6 of

3 Courter’s reply brief and Exhibit D to the Reply Declaration of Bradley S. Keller. Dkt. 4 54. Kodali and Courter contest who suffered the greater loss and therefore has the largest 5 financial interest in the relief sought by the class. 6 Kodali argues for the first time in reply that the Courter’s losses do not comply 7 with Dura Pharmaceuticals, Inc. v. Broudo, 544 U.S. 336 (2005).2 She asserts that 8 Courter’s losses are incalculable as required by Dura because Courter’s losses were

9 incurred prior to the disclosures about the alleged misrepresentations. 10 Courter has not had the opportunity to respond to this new argument, and the 11 Court therefore requests a surreply from Courter as to whether his losses are proximately 12 caused by CytoDyn’s misrepresentations as required by Dura. Courter shall file a 13 surreply no later than July 30, 2021, and the surreply shall be no longer than five pages.

14 The Clerk shall renote the pending motions to consolidate actions, appoint lead plaintiff, 15 and approve selection of lead and liaison for the Court’s July 30, 2021 calendar. 16 IT IS SO ORDERD. 17 Dated this 22nd day of July, 2021. A 18 19 BENJAMIN H. SETTLE 20 United States District Judge 21 2 Kodali cites Dura in passing in her response, see Dkt. 45 at 3–4, but does not make the 22 explicit arguments that Courter’s losses are not Dura-compliant.